Explore News By Topic


The Prostate Cancer Foundation, in Collaboration With World’s Leading Researchers, Publish Standard Setting Comprehensive Patient Guide

Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families LOS ANGELES, CA, September 14, 2017 – The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer... Read More


Dax Shepard, Dr. Drew Pinsky and Rob Riggle Join the Prostate Cancer Foundation with an Urgent Plea to ‘Save the Males’ for Prostate Cancer Awareness Month

LOS ANGELES, CA, September 5, 2017 – – In recognition of Prostate Cancer Awareness Month, Many vs Cancer (MvC) today launched its new campaign, Save the Males, with support from Dax Shepard, Dr. Drew Pinsky and Rob Riggle. This new campaign from the Prostate Cancer Foundation’s MvC initiative aims to... Read More


Prostate Cancer Foundation Announces Six 2017 Challenge Awards Funded in Partnership with the Movember Foundation

SANTA MONICA, CA, August 23, 2017 – The Prostate Cancer Foundation (PCF) today announced six new Challenge Awards funded in partnership with the Movember Foundation. These multi-year awards support cross-disciplinary teams of investigators conducting pioneering research to advance treatments and cures for prostate cancer. PCF received a donation of $5.4... Read More


Statistical Shortcut Could Speed Evaluation of Prostate Cancer Drugs

Clinical trials of adjuvant therapies used in treating some men with prostate cancer could be completed more quickly by using a “surrogate” endpoint, scientists report The investigators found that metastasis-free survival – how long patients survived without the cancer spreading – was a strong predictor of their overall survival BOSTON,... Read More


Researchers make mathematical crystal ball to gaze into future of prostate cancer treatment

Aurora, CO, August 4, 2017 - The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been better off with another treatment or alternative dosing of docetaxel... Read More


Comprehensive sequencing program shows promise of precision medicine for advanced cancer

ANN ARBOR, Michigan, August 2, 2017 — The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors... Read More


Prostate Cancer Foundation Announces 2017 Young Investigator Award Recipients

SANTA MONICA, CA, July 10, 2017 -- The Prostate Cancer Foundation (PCF) today announced its 2017 Young Investigator (YI) Awards, which support early career scientists who are focused on accelerating the delivery of life-extending and life-saving therapies for men living with prostate cancer. The YI Awards provide three years of... Read More


New three-in-one blood test opens door to precision medicine for prostate cancer

Test picks out men for treatment, detects early signs of resistance and monitors cancer’s evolution over time Advance is part of strategic push to overcome cancer evolution and drug resistance   LONDON, June 18, 2017  - Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate... Read More


Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival

ASCO Perspective “For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,” said Sumanta Kumar Pal, MD, ASCO Expert. “This is good news because using abiraterone could help many people live longer with fairly few additional side... Read More


Prostate Cancer Foundation and Major League Baseball Launch Annual Home Run Challenge to Defeat Prostate Cancer

LOS ANGELES, June 1, 2017 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are launching the annual Home Run Challenge on June 1, and running through Father's Day, June 18, in all 30 MLB ballparks throughout the United States and Canada. For the first time, all MLB... Read More